- Healthcare 150
- Posts
- Healthcare M&A Strategy Is Shifting Toward Discipline
Healthcare M&A Strategy Is Shifting Toward Discipline
Healthcare dealmaking hasn’t stopped — but the playbook is clearly evolving.

In our latest proprietary Healthcare 150 microsurvey (N=198), investors and operators signaled that capital constraints, valuation uncertainty, and operational complexity are reshaping how deals get done. Rather than pursuing aggressive platform expansions, buyers are prioritizing discipline, specialization, and operational visibility before committing capital.

The most common strategy shift is smaller platform deals combined with add-on acquisitions, cited by 24% of respondents overall and 40% of C-suite leaders. The approach reflects a more measured growth strategy: build platforms gradually, integrate acquisitions carefully, and scale through operational improvement rather than headline valuations.
Other respondents pointed to longer hold periods and structured or minority investments, both at 21% of responses. These structures allow investors to maintain exposure to attractive assets while managing risk in a higher-cost capital environment.
At the same time, sector specialization is intensifying. Corporate development leaders overwhelmingly highlighted a more selective sector focus (67%), suggesting that buyers are concentrating capital in subsectors where they have deeper operating expertise and clearer demand visibility.
Operational diligence is also becoming more prominent. Among healthcare M&A specialists, 50% cited greater pre-close operational diligence, reflecting the growing importance of reimbursement dynamics, labor costs, and regulatory complexity in determining asset performance.
Perhaps the most striking signal comes from the investment community itself: 100% of investment management respondents pointed to deeper operational diligence before closing deals. In today’s environment, financial engineering alone is no longer enough — operational execution is increasingly the primary driver of value creation.
The message from the data is clear. Healthcare M&A is moving from expansion to precision. Investors are still deploying capital, but they are doing so with smaller platforms, deeper diligence, and more targeted sector expertise.
In a market defined by tighter financing and higher scrutiny, the winners will likely be sponsors who combine disciplined deal selection with strong operational capabilities after the acquisition.